fastest
TRANSCRIPT
# 21. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
FAsTEST has devised a new method for analysis of fatty acids (including Omega3), which allows reducing the time and cost compared to other FA analysis.
Customers are Medical brokers, Laboratories, Pharma and Wellness Companies
Company highlightsCompany highlights
Heal t h and Psychol ogical S t at us
Diet and L if eS t yl e
Fat t y Acids l evel s in bl ood
# 31. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
Products & services overviewProducts & services overview
Fatty Acid Test in the blood
Studies and research for companies / entities
Partnership
Pro
du
cts
Ser
vice
s
Pro
du
cts
Ser
vice
s
The activities do not have environmental impacts.
Use of non-toxic gas.
Limited energy
♥
# 41. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
Market overview and market entryMarket overview and market entry
StudiesFatty Acid Test
Collaboration Contracts
• Research Institutions and Companies interested in studies with the aim of aligning products to customer needs
• Medical-Scientific Brokers such as pharmacies, health centers, health care facilities, laboratories, medical specialists who are interested in the performance and applications in care prevention.
• Company Py-Intensive where it is essential physical and mental readiness for the conduct of business. Examples are sports clubs in general, activities with high responsibilities like public transport, airlines, military.
Research Institutions and CompaniesBrokers Medical-Scientific
Company Py-Intensive
Population:
World 6.790 mlnEurope EU 495 mln United States 307 mlnItaly 58 mlnBenelux 28 mlnPoland 38 mln(July 2009 est.) Source CIA World Factbook
65 mln people TARGET
1.200 Research Institutions and Companies50.000 Brokers and Practitioners500 Py-Intensive Companies
# 51. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
Partners and collaboratorsPartners and collaboratorsAddresses Headquarters - Viale Tunisia, 38 - 20124 Milano
Funding Received
2006 Winner of Match Compteneze2007 Imprese Creative2009 Bank Financing2009 Startup at Parco tecnologico Padano – Lodi2009 Selected for “Italian Business Angels - Early Stage”
SomeStudies...
Study about the effects of moderate amounts of dairy products with Omega3
Study of different oils and their use in the preparation of bakery
Effects of their horse meat on circulating levels of omega 3 fatty acids in healthy individuals
Levels of Omega 3 in the blood and neurodegenerative diseases
Omega 3 and PND
Levels of DHA during pregnancy
Profiles in AG in malnourished child population in Cambodia
Effects of supplementation with DHA in children with cystic fibrosis
Effects of cigarette smoking during pregnancy
Fatty acids as indicators of risk of stroke and cardiovascular disease
Dental disorders and fatty acids
AG in the elderly population in relation to Alzheimer's...
Partners Under finalisation a commercial agreement for benelux territories
We are looking for partners interested in money, competence and
relations with target customers
# 61. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
CompetitionCompetition
Competition and Competitive AdvantageCompetitors: Italy and abroad small companies doing analysis of the AG with different methodologies
Lower prices methodologies are not rigorous Higher prices are not justified FASTEST is a reference for many competitors
EntrantsTo reach customers there are high barriers to entry to the sales channelsThe execution of studies require scientific accreditation that is the result of years of work
SuppliersEquipment and Supplies do not have
critical supply
SynergiesFoods and supplements with Omega3
Low analysis price
Team Skills and capabilities
Fatty Acid database with optimum levels
Ability to Innovate and Implement
Need Investment
Need to overcome the barriers to enter into the market
Barriers to entry into the sales channels (pharmacies, care centers, hospitals, ...)
In the case of several attractive market competitors may arise
Good time for the services offered
Available Technology and materials
Advantage over competitors
Weaknesses
Opportunities Threats
Strengths
# 71. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
Barriers to entryBarriers to entry
Fo
od
-Fu
nct
ion
al F
oo
d
FAsTEST: Competence in Fatty Acids Analysis+
Network for Healthcare promotion and disease prevention =
Fatty Acid analysis for driving food balance for Wellness
Scientific Findings
PreventionWellness
PreventionWellness
Needs
# 81. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
Management teamManagement team
Claudio Galli – Partner – Scientific Management, R & D Laboratory Manager
Degree in Medicine and Surgery, Professor at the Faculty of Pharmacy, Univ Milan. He has published over 200 scientific articles. In the past, President of the International Society for the Study of Fatty Acids and Lipids (ISSFAL), Director of the Center for Pharmacoeconomics, Director of School of Toxicology.
Franca Marangoni - Director and Partner – Marketing, Sales
Degree in Chemistry and Technology Pharmacology - PhD. Doctor of research in food toxicology. Scientific
coordinator N.F.I. (Nutrition Fundation International). Franca has performed studies for Danone, Novartis, Parmalat on innovative food products with Omega3.
Davide Cilano – Director and Partner – Administration, Finance, Information Technology
Degree in Computer Science with MBA and experience in project management and Business process reingeneering in many industry sectors (Finance, Multimedia, Consumer goods, Pharma).
# 91. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
Financial projections and Investment opportunityFinancial projections and Investment opportunityBelgium, Netherlands, Luxembourg, Poland
BEP
FAsTEST
Commission 30%
I° Profit m. 45%II° Profit m.25%
Public Institutions and Companies.
People
I° Profit m. 75%II ° Profit m.25%
Company Py-Intensive
Brokers Medical-Scientific
Financials Removed on Public version
# 101. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
Use of funds and Exit strategyUse of funds and Exit strategy
Financials Removed on Public version
# 111. Company 2. Products 3. Market 4. Partners 5. Competition 6. Barriers 7. Team 8. Financial 9. Summary
Resources needed beyond capitalResources needed beyond capital
♥ www.fastest.it
“ Laboratory for Fatty Acid analysis and research “Needs:
Partnership for products and services promotion andMarketing plan competences